New studies shed light on the potential role of monoclonal antibodies in migraine prophylaxis and in Parkinson disease and on a common genetic pathway shared by PD and autoimmune diseases.
Treating Rare Cases of Spinal Meningioma Using Complex Surgical Tactics
Sleeping Around the Podcast × NeurologyLive: Erenumab, Migraine, and Sleep
Potential of Advancing Neurofibromatosis Care With Investigational Mirdametinib
Episode 119: Utilizing the Syn-One Test to Diagnose Parkinson Disease
FDA Accepts Resubmitted New Drug Application for Migraine Treatment AXS-07
FDA Clears Clearmind Biomedical’s Neuroblade System for Minimally Invasive Neurosurgery